Early Phase 1 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged 18 or older who have been diagnosed with prostate cancer (a specific type called adenocarcinoma) that has spread to other parts of the body and is planned to be treated with hormone-blocking therapy (called ADT)
- People who have had recent imaging of the body, either a CT scan of the abdomen and pelvis plus a bone scan, or a special type of scan called a PSMA PET scan
Who may not be able to join:
- Men under 18 years of age
- People whose prostate cancer is a rare type called neuroendocrine prostate cancer
- People who have received hormone-blocking therapy (ADT) at any point in the year before joining the trial
- People who are planning to take or are currently taking chromium supplements during the trial period
- People who are planning to take or are currently taking apple cider vinegar supplements during the trial period
- People who are not able to give informed consent, or who cannot understand or read English, unless an interpreter is available to assist
- People with poor liver function above a certain level (confirm with trial site)
- People with any other health condition, long-term illness, or lifestyle factor that the trial doctor believes could affect the person's ability to complete the trial or could put them at risk
- People who are taking antibiotics that cannot be stopped before the trial starts and kept off for the entire duration of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Melissa Huynh, MD, Western University
Phone: 519-685-8500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fecal Akkermansia muciniphilia counts; Fecal Akkermansia muciniphilia counts; Fecal Akkermansia muciniphilia counts; Fecal Akkermansia muciniphilia counts; Fecal Akkermansia muciniphilia counts; Side effects and tolerability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.